Related Experiment Video

Updated: Mar 28, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.6K

No Resistance to Penicillin, Cefuroxime, Cefotaxime, or Vancomycin in Pneumococcal Pneumonia

Josef Yayan1, Beniam Ghebremedhin2, Kurt Rasche1

  • 11. Witten/Herdecke University, Witten, Department of Internal Medicine, Division of Pulmonary, Allergy, and Sleep Medicine, HELIOS Clinic Wuppertal, Germany.

International Journal of Medical Sciences
|December 15, 2015
PubMed
Abstract

Insights

Group B Streptococcus pneumonia shows high resistance to common antibiotics like gentamicin and erythromycin. However, penicillin and other key antibiotics remain effective treatments for this serious infection.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Pulmonary Medicine

Background:

  • Group B Streptococcus (GBS) is a significant cause of pneumonia, a leading global cause of mortality.
  • Increasing antibiotic resistance in GBS strains poses a growing clinical challenge.
  • This study investigates antimicrobial resistance patterns in GBS pneumonia patients.

Purpose of the Study:

  • To retrospectively analyze antimicrobial resistance in Group B Streptococcus pneumonia.
  • To identify resistance trends in GBS to commonly administered antibiotics in an inpatient setting.

Main Methods:

  • Retrospective analysis of inpatient data from HELIOS Clinic Wuppertal (2004-2014).
  • Inclusion of patients diagnosed with Group B Streptococcus pneumonia.
  • Antimicrobial susceptibility testing for various administered antimicrobial agents.

Main Results:

  • Sixty-six inpatients with GBS pneumonia were identified (mean age 63.3 years; 68.2% male).
  • High resistance rates observed for gentamicin (12.1%), erythromycin (12.1%), and clindamycin (9.1%).
  • No resistance detected to penicillin, cefuroxime, cefotaxime, or vancomycin (P < 0.0001).

Conclusions:

  • Penicillin, cefuroxime, cefotaxime, and vancomycin demonstrated no resistance in GBS pneumonia cases.
  • These findings highlight the continued efficacy of specific antibiotics against GBS pneumonia.
  • Monitoring antimicrobial resistance is crucial for effective GBS pneumonia management.
Keywords:
AntibioticGroup B StreptococcusPneumoniaResistanceSensitivity

More Related Videos

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

2.3K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
95
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
37
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
39
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
29
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
58